A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
A5132 TRIAL TO EVALUATE INTERLEUKIN-2 (IL-2) POTENT ANTIRETROVIRAL THERAPY
批准号:
7605184
负责人:
THOMAS C MERIGAN
金额:
$0.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-15 至 2007-11-30
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
A5132是一项探索性、开放标签、随机试验,旨在评估IL-2增强HIV特异性免疫应答的能力,并影响强效抗逆转录病毒治疗(ART)中断后的病毒学反弹率。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
A5132 is an exploratory, open-label, randomized trial to evaluate the ability of IL-2 to enhance HIV-specific immune responses and influence the rate of virologic rebound following potent antiretroviral therapy (ART) interruptions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MANAGEMENT OF HEPATITIS C VIRUS (HCV) AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7605200
-
项目类别:
-
资助金额:$4.74万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7605165
-
项目类别:
-
资助金额:$2.09万
-
财政年份:2007
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7375261
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7375239
-
项目类别:
-
资助金额:$0.89万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7375194
-
项目类别:
-
资助金额:$1.33万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7375233
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2005
-
负责人:THOMAS C MERIGAN
-
依托单位:
ACTG 5001 ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED
-
批准号:7202022
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
VIROLOGIC STUDIES IN COMPARTMENTAL SAMPLES FROM HIV-INFECTED SUBJECTS
-
批准号:7202038
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PROTEASE INHIBITOR-SPARING REGIMENS FOR THE INITIAL TREATMENT OF HIV INFECTION
-
批准号:7202039
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
RIBAVIRIN ON ZIDOVUDINE OR STAVUDINE TRIPHOSPHATE FORMATION A5092S IN AIDS
-
批准号:7202053
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TRIAL OF VALGANCICLOVIR ACTG 5030 AIDS STUDY
-
批准号:7202032
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
TREATMENT OF ELEVATED NON-HDL CHOLESTEROL AND ELEVATED TRIGLYCERIDES IN HIV
-
批准号:7202065
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
PULSE THERAPY ON THE CHARACTERISTICS OF TREATMENT INTERRUPTIONS AIDS
-
批准号:7202042
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
GENE CONSTRUCT IN THE TREATMENT OF PATIENTS WITH HIV-1 INFECTION
-
批准号:7202052
-
项目类别:
-
资助金额:$9.08万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
DETERMINE TIME TO DEVELOPMENT OF AIDS DEFINING COMPLICATIONS & INFECTIONS
-
批准号:7202023
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
STUDY ON ABILITY TO ENHANCE HIV-SPECIFIC IMMUNE RESPONSES
-
批准号:7202080
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH DECREASED BONE MINERAL DENSITY RECEIVING CALCIUM AND VITAMIN D
-
批准号:7202085
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
ANTIVIRAL MANAGEMENT OF HEPATITIS C VIRUS AND HIV-1 CO-INFECTED SUBJECTS
-
批准号:7202114
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
HIV SUBJECTS WITH FAILURE OF PREVIOUS PROTEASE INHIBITOR-BASED REGIMENS
-
批准号:7202075
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2004
-
负责人:THOMAS C MERIGAN
-
依托单位:
A5132 AN EXPLORATORY, OPEN-LABEL, RANDOMIZED TRIAL
-
批准号:6980971
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2003
-
负责人:THOMAS C MERIGAN
-
依托单位:
海外基金